It looks like Pfizer is not the only Pharma Company with it's checkbook out.
The Wall Street Journal quotes Merck's Chief Executive Richard Clark as saying that "Merck would look 'across the whole spectrum' of deals, including a major takeover. 'I don't think in today's world any CEO can categorically rule out any type of transaction,' "
Traditionally Merck has been proud of its internal R&D programs.
But now apparently Merck wants to go shopping too.
Subscribe to:
Post Comments (Atom)
.jpg)
No comments:
Post a Comment